Cara Therapeutics Inc (CARA): מקדם החזר מותאם קצב צמיחה

Cara Therapeutics, Inc. (CARA) revenues are based on Korsuva sales and partnership payments. The adjusted P/E relative to growth rates demonstrates the asset's value dynamics, where 0.00 captures the current state of the parameter. Management is currently cutting costs following failed tests, while crisis management, under pressure from shareholders, is exploring new business development options.
פילוחים אנליטיים של חברת Cara Therapeutics (CARA)

The PEG ratio correlates the P/E ratio with earnings growth rates to determine whether an asset's market value is justified by its growth dynamics. Amidst the critical crisis facing Cara Therapeutics, Inc. (CARA) and the suspension of difelikefalin trials, the PEG fair value filter on GURU.Markets helps identify false undervaluation, where a low multiple masks the risk of total business liquidation due to the depletion of cash reserves.